Immunomodulatory effect of vancomycin on Treg in pediatric inflammatory bowel disease and primary sclerosing cholangitis

Journal of Clinical Immunology

Volumn 33, Issue 2, 2013, Pages 397-406

  Abarbanel, David N ^a   Seki, Scott M ^a   Davies, Yinka ^c   Marlen, Natalie ^c   Benavides, Joseph A ^a   Cox, Kathleen ^a,b   Nadeau, Kari C ^a,b   Cox, Kenneth L ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c Sutter Institute for Medical Research   (United States)

Author keywords

Inflammatory bowel disease; Primary sclerosing cholangitis; Regulatory Tcell; Vancomycin

Indexed keywords

ALANINE AMINOTRANSFERASE; CD4 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BILIARY TRACT RADIOGRAPHY; CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DRUG RESPONSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VIVO STUDY; INTESTINE BIOPSY; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER FUNCTION TEST; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NEUTROPHIL COUNT; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RELAPSE; SCHOOL CHILD; SYMPTOM; TH1 CELL; TH2 CELL; ULCERATIVE COLITIS;

EID: 84879887023     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-012-9801-1     Document Type: Article

References (33)

1. Howden BP, Smith DJ, Mansell A, Johnson PD, Ward PB, Stinear TP, et al. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillinresistant Staphylococcus aureus bacteraemia. BMC Microbiol. 2008;8:39. doi:10.1186/1471-2180-8-39.
2. Cox KL, Cox KM. Oral vancomycin: Treatment of primary sclerosing cholangitis in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1998;27(5):580-3.
3. Davies YK, Cox KM, Abdullah BA, Safta A, Terry AB, Cox KL. Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr. 2008;47(1):61-7. doi:10.1097/MPG.0b013e31816fee95.
4. Mieli-Vergani GaDV. Unique features of primary sclerosing cholangitis in children. Curr Opin Gastroenterol.26(3):4.
5. Bowlus CL. Cutting edge issues in primary sclerosing cholangitis. Clin Rev Allergy Immunol. 2011;41(2):139-50. doi:10.1007/s12016-010-8221-3.
6. Hov JR, Kosmoliaptsis V, Traherne JA, Olsson M, Boberg KM, Bergquist A, et al. Electrostatic modifications of the human leukocyte antigen-DR P9 peptide-binding pocket and susceptibility to primary sclerosing cholangitis. Hepatology. 2011;53(6):1967-76. doi:10.1002/hep. 24299.
7. Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, et al. Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology. 2010;138(3):1102-11. doi:10.1053/j.gastro.2009.11.046.
8. Melum E, Franke A, Schramm C, Weismuller TJ, Gotthardt DN, Offner FA, et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet. 2011;43(1):17-9. doi:10.1038/ng.728.
9. Ochoa-Reparaz J, Mielcarz DW, Ditrio LE, Burroughs AR, Foureau DM, Haque-Begum S, et al. Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis. J Immunol. 2009;183(10):6041-50. doi:10.4049/jimmunol.0900747.
10. Ivanov, II, Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell host & microbe. 2008;4(4):337-49. doi:10.1016/j.chom.2008.09.009
11. Wu HJ, Ivanov II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity. 2010;32(6):815-27. doi:10.1016/j.immuni.2010.06.001.
12. Lathrop SK, Bloom SM, Rao SM, Nutsch K, Lio CW, Santacruz N, et al. Peripheral education of the immune system by colonic commensal microbiota. Nature. 2011;478(7368):250-4. doi:10.1038/nature10434.
13. Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature. 2012;482(7385):395-9. doi:10.1038/nature10772.
14. Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337-41. doi:10.1126/science.1198469.
15. Strauch UG, Obermeier F, Grunwald N, Gurster S, Dunger N, Schultz M, et al. Influence of intestinal bacteria on induction of regulatory T cells: Lessons from a transfer model of colitis. Gut. 2005;54(11):1546-52. doi:10.1136/gut.2004.059451.
16. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A. 2010;107(27):12204-9. doi:10.1073/pnas.0909122107.
17. Liu B, Tonkonogy SL, Sartor RB. Antigen-presenting cell production of IL-10 inhibits T-helper 1 and 17 cell responses and suppresses colitis in mice. Gastroenterology. 2011;141(2):653-62. doi:10.1053/j.gastro.2011.04.053. 62 e1-4.
18. Nguyen KD, Vanichsarn C, Fohner A, Nadeau KC. Selective deregulation in chemokine signaling pathways of CD4+CD25(hi)CD127 (lo)/(-) regulatory T cells in human allergic asthma. J Allergy Clin Immunol. 2009;123(4):933-9. doi:10.1016/j.jaci.2008.11.037. e10.
19. Siedlar M, et al. Vancomycin down-regulates lipopolysaccharideinduced tumour necrosis factor alpha (TNF alpha) production and TNF alpha-mRNA accumulation in human blood monocytes. Immunopharmacology. 1997;35(3):7.
20. Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006;203 (7):1701-11. doi:10.1084/jem.20060772.
21. Lichtman SN, Okoruwa EE, Keku J, Schwab JH, Sartor RB. Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth. J Clin Investig. 1992;90(4):1313-22. doi:10.1172/JCI115996.
22. Lichtman SN, Sartor RB, Keku J, Schwab JH. Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology. 1990;98(2):414-23.
23. Yoshimura A, Wakabayashi Y, Mori T. Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem. 2010;147(6):781-92. doi:10.1093/jb/mvq043.
24. Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, et al. Conversion of peripheral CD4+CD25-naive T cells to CD4+ CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003;198(12):1875-86. doi:10.1084/jem.20030152.
25. Fu S, Zhang N, Yopp AC, Chen D, Mao M, Chen D, et al. TGFbeta induces Foxp3+T-regulatory cells from CD4+CD25 - precursors. Am J Transplant. 2004;4(10):1614-27. doi:10.1111/j.1600-6143.2004.00566.x.
26. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133(5):775-87. doi:10.1016/j.cell.2008.05.009.
27. Kim YM, Munoz A, Hwang PH, Nadeau KC. Migration of regulatory T cells toward airway epithelial cells is impaired in chronic rhinosinusitis with nasal polyposis. Clin Immunol. 2010;137 (1):111-21. doi:10.1016/j.clim.2010.05.013.
28. Nguyen KD, Vanichsarn C, Nadeau KC. Impaired IL-10-dependent induction of tolerogenic dendritic cells by CD4+ CD25hiCD127lo/-natural regulatory T cells in human allergic asthma. Am J Respir Crit Care Med. 2009;180(9):823-33. doi:10.1164/rccm.200905-0761OC.
29. Nguyen KD, Vanichsarn C, Nadeau KC. TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin Immunol. 2010;6(1):4. doi:10.1186/1710-1492-6-4.
30. Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring regulatory T cells: Markers, mechanisms, and manipulation. Faseb J. 2012;26(6):2253-76. doi:10.1096/fj.11-193672.
31. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10- deficient mice develop chronic enterocolitis. Cell. 1993;75 (2):263-74.
32. Rubtsov YP, Rasmussen JP, Chi EY, Fontenot J, Castelli L, Ye X, et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity. 2008;28(4):546-58. doi:10.1016/j.immuni.2008.02.017.
33. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gramnegative bacteria preferentially stimulate IL-10 production. Infect Immun. 2000;68(6):3581-6.